Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;22(3):156-61.
doi: 10.1016/j.suronc.2013.04.002. Epub 2013 May 20.

Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes

Affiliations
Review

Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes

David Fedor et al. Surg Oncol. 2013 Sep.

Abstract

Purpose: To date, few large-scale original studies have focused specifically on local recurrence following curative lung cancer surgery. This review seeks to consolidate and analyze data from these studies regarding local recurrence incidence, risk factors, salvage treatments, and outcomes to increase awareness in the Oncology community and to spark new research in this area.

Methods: PubMed literature was searched for large-scale cohort studies involving recurrence following lung cancer surgery. Studies with a primary focus on local recurrence and studies that examined overall recurrence but provided relevant numerical data on local recurrence were included. Each chosen study's methods were critically analyzed to reconcile as best as possible large differences in reported results across the studies.

Results: Up to 24% of patients recur locally following lung cancer surgery. Risk of local recurrence increases with the stage of the primary cancer, but even stage I patients experience local recurrence up to 19% of the time. Overall survival time following local recurrence varies widely across studies, from 7 to 26 months, and may be related to frequency of follow-up visits. Salvage therapy appears to increase survival time. However, estimates of this increase vary widely, and measurements of benefits of the various salvage options are confounded by lack of control of subjects' condition at the time of salvage therapy administration.

Conclusions: Local recurrence following lung cancer surgery is a significant problem warranting additional research. At present, data on this topic is scarce. We recommend initiation of additional large-scale studies to clearly define the parameters of local recurrence in order to provide useful guidance to clinicians.

Keywords: Cancer; Local; Lung; Recurrence; Resection; Surgery; Tumor.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

The authors have no conflicts of interest or funding sources to report.

References

    1. Choi SH, Kim YT, Kim SK, Kang KW, Goo JM, Kang CH, et al. Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer. Ann Thorac Surg. 2011;92(5):1826–1832. - PubMed
    1. Alberts WM. Follow up and surveillance of the patient with lung cancer: what do you do after surgery? Respirology. 2007;12(1):16–21. - PubMed
    1. Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML. Productivity costs of cancer mortality in the United States, 2000–2020. J Natl Cancer Inst. 2008;100(24):1763–1770. - PMC - PubMed
    1. Aliperti LA, Predina JD, Vachani A, Singhal S. Local and systemic recurrence is the Achilles Heel of cancer surgery. Ann Surg Oncol. 2011;18(3):603–607. - PMC - PubMed
    1. Taylor MD, Nagji AS, Bhamidipati CM, Theodosakis N, Kozower BD, Lau CL, et al. Tumor recurrence after complete resection for non-small cell lung cancer. Ann Thorac Surg. 2012;93(6):1813–1821. - PubMed